A Dual CRISPR-Cas/Cre- loxP Genome Engineering Strategy for Stable Uricase Expression in Food-Grade Probiotics
ACS Synthetic Biology · 16.01.2026 · 15 (1) · 331-341
DOI: 10.1021/acssynbio.5c00774 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 23.12.2025. Verfasst von Xiaoyuan Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Shanghai Engineering Research Center of Immunotherapeutics, Fudan University, Shanghai 201203, PR China. Hauptthemen laut MEDLINE: Probiotics, CRISPR-Cas Systems, Lactococcus lactis, Urate Oxidase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Shanghai Engineering Research Center of Immunotherapeutics, Fudan University, Shanghai 201203, PR China.
- China State Institute of Pharmaceutical Industry, Shanghai 201203, PR China.
ORCID-Profile: Xiaoyuan Tang, Dianwen Ju
Zitieren
APA
Tang, X., Ju, D., & Hu, H. (2026). A Dual CRISPR-Cas/Cre- loxP Genome Engineering Strategy for Stable Uricase Expression in Food-Grade Probiotics. ACS Synthetic Biology, 15(1), 331-341. https://doi.org/10.1021/acssynbio.5c00774
Vancouver
Tang X, Ju D, Hu H. A Dual CRISPR-Cas/Cre- loxP Genome Engineering Strategy for Stable Uricase Expression in Food-Grade Probiotics. ACS Synthetic Biology. 2026;15(1):331-341. doi:10.1021/acssynbio.5c00774
BibTeX
@article{Tang2026,
author = {Tang, Xiaoyuan and Ju, Dianwen and Hu, Haifeng},
title = {A Dual CRISPR-Cas/Cre- loxP Genome Engineering Strategy for Stable Uricase Expression in Food-Grade Probiotics},
journal = {ACS Synthetic Biology},
year = {2026},
volume = {15},
number = {1},
pages = {331--341},
doi = {10.1021/acssynbio.5c00774}
}
EUVIMED